The sector has come out of its worst phase and is likely to witness an earnings uptrend in the next 1-3 years. The Indian pharma industry is one of the ...
Read more: Earnings will accelerate if no macro headwinds occur: Sailesh Raj Bhan, Reliance Mutual Fund